2021 annual financial data

Edesa Biotech 2021 Operating margin

Direct answer

Operating margin was -4,736,266.4%.

Operating income was -23.68M USD and net income was -13.34M USD.
Operating cash flow was -13.66M USD.

Get free Edesa Biotech email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
500 USD
Operating income
-23.68M USD
Net income
-13.34M USD
Operating cash flow
-13.66M USD